2024
DOI: 10.46531/sinapse/cc/220038/2022
|View full text |Cite
|
Sign up to set email alerts
|

Generalized Epilepsy in a Patient with GBJ1 X-Linked Charcot-Marie-Tooth Disease

Abstract: Charcot-Marie-Tooth (CMT) disease is an inherited neuropathy known for its genetic and phenotypic heterogeneity. Although unusual, the involvement of the central nervous system (CNS) has also been reported, including epilepsy.A 23-year-old man who at the age of 8 started to develop a gait disturbance. His neurological examination revealed distal weakness, muscular atrophy of the four limbs and decreased deep tendon reflexes. The electromyogram and nerve conduction study revealed a chronic symmetric axonal sens… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 23 publications
0
0
0
Order By: Relevance
“…SBF1 is a target gene commonly associated with a neurological disorder, Charcot Marie Tooth disease (CMT) [52], and is highly expressed in the brain region "https://www.proteinatlas.org/ENSG00000100241-SBF1/tissue (accessed on 20 October 2022)". The clinical evidence of epilepsy in patients with CMT [53][54][55][56] and hypermethylation of SBF1 in patients with Drug-resistant Temporal Lobe Epilepsy [57] highlights the role of the SBF1 gene in epilepsy. The other gene identified in our study, BRD1, is associated with neuropsychiatric disorders such as schizophrenia and bipolar disorder along with its impact on neurodevelopmental disorders [58,59].…”
Section: Discussionmentioning
confidence: 99%
“…SBF1 is a target gene commonly associated with a neurological disorder, Charcot Marie Tooth disease (CMT) [52], and is highly expressed in the brain region "https://www.proteinatlas.org/ENSG00000100241-SBF1/tissue (accessed on 20 October 2022)". The clinical evidence of epilepsy in patients with CMT [53][54][55][56] and hypermethylation of SBF1 in patients with Drug-resistant Temporal Lobe Epilepsy [57] highlights the role of the SBF1 gene in epilepsy. The other gene identified in our study, BRD1, is associated with neuropsychiatric disorders such as schizophrenia and bipolar disorder along with its impact on neurodevelopmental disorders [58,59].…”
Section: Discussionmentioning
confidence: 99%